Lexaria Bioscience Corp. (LEXX) › Net IncomeLexaria Bioscience Corp. (LEXX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$552.5K2011: -$538.2K2014: -$1.56M2015: -$1.98M2016: -$1.28M2017: -$1.93M2018: -$6.61M2019: -$4.16M2020: -$4.08M2021: -$4.03M2022: -$7.27M2023: -$6.66M2024: -$5.80M2025: -$11.90M-$11.90M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$11.90M-105.4%2024-$5.80M+13.0%2023-$6.66M+8.3%2022-$7.27M-80.5%2021-$4.03M+1.4%2020-$4.08M+1.8%2019-$4.16M+37.1%2018-$6.61M-242.5%2017-$1.93M-51.1%2016-$1.28M+35.6%2015-$1.98M-27.2%2014-$1.56M—2011-$538.2K+2.6%2010-$552.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share